Work

Abstract PS4-07-29: Evaluating the tolerability of the combination of adjuvant pembrolizumab and capecitabine in a diverse real-world cohort of patients with early-stage TNBC

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-07-29

Authors: J. Anderson, E. Baldwin, J. Dejesus, G. Van Hyfte, P. Pandu, N. Krishnamurthy, M. Rattu, R. Farley, R. Patel, A. Tiersten

Institutions: Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129296954

Cites:

Cited by:

Related to: